DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,872 | +0.7% | 342,087 | -2.6% | 2.13% | +5.1% |
| Q2 2023 | $84,321 | -5.0% | 351,336 | -0.2% | 2.02% | -10.4% |
| Q1 2023 | $88,725 | -5.4% | 352,027 | -0.4% | 2.26% | -10.6% |
| Q4 2022 | $93,778 | -99.9% | 353,319 | -0.1% | 2.53% | -4.6% |
| Q3 2022 | $91,341,000 | +3.9% | 353,638 | +1.9% | 2.65% | +8.0% |
| Q2 2022 | $87,949,000 | -13.4% | 346,912 | +0.2% | 2.45% | +1.4% |
| Q1 2022 | $101,532,000 | -11.1% | 346,136 | -0.3% | 2.42% | -5.1% |
| Q4 2021 | $114,272,000 | +6.4% | 347,320 | -1.5% | 2.55% | -4.4% |
| Q3 2021 | $107,400,000 | +10.3% | 352,779 | -2.7% | 2.66% | +8.8% |
| Q2 2021 | $97,346,000 | +17.2% | 362,744 | -1.7% | 2.45% | +7.2% |
| Q1 2021 | $83,069,000 | -1.2% | 369,066 | -2.5% | 2.28% | -5.5% |
| Q4 2020 | $84,104,000 | +1.2% | 378,609 | -1.9% | 2.41% | -11.2% |
| Q3 2020 | $83,135,000 | +20.0% | 386,080 | -1.4% | 2.72% | +10.1% |
| Q2 2020 | $69,252,000 | +26.9% | 391,631 | -0.7% | 2.47% | +8.8% |
| Q1 2020 | $54,572,000 | -12.0% | 394,276 | -2.4% | 2.27% | +11.6% |
| Q4 2019 | $61,991,000 | +4.9% | 403,900 | -1.3% | 2.03% | -2.4% |
| Q3 2019 | $59,097,000 | +0.4% | 409,175 | -0.6% | 2.08% | -0.6% |
| Q2 2019 | $58,856,000 | +6.5% | 411,810 | -1.6% | 2.09% | +1.8% |
| Q1 2019 | $55,242,000 | +26.4% | 418,434 | -1.3% | 2.06% | +14.9% |
| Q4 2018 | $43,718,000 | -3.9% | 423,948 | +1.3% | 1.79% | +8.4% |
| Q3 2018 | $45,487,000 | +10.8% | 418,620 | +0.6% | 1.65% | +3.4% |
| Q2 2018 | $41,046,000 | +1.5% | 415,954 | +0.7% | 1.60% | -0.9% |
| Q1 2018 | $40,442,000 | +6.7% | 413,057 | +1.1% | 1.61% | +8.4% |
| Q4 2017 | $37,909,000 | +8.8% | 408,410 | +0.5% | 1.49% | +3.3% |
| Q3 2017 | $34,845,000 | +2.6% | 406,211 | +0.9% | 1.44% | +0.3% |
| Q2 2017 | $33,977,000 | +0.4% | 402,619 | +1.7% | 1.44% | -6.1% |
| Q1 2017 | $33,844,000 | +11.0% | 395,701 | +1.0% | 1.53% | +5.0% |
| Q4 2016 | $30,483,000 | +3.4% | 391,606 | +4.1% | 1.46% | +1.3% |
| Q3 2016 | $29,494,000 | -21.0% | 376,246 | +1.8% | 1.44% | -21.6% |
| Q2 2016 | $37,346,000 | +6.7% | 369,759 | +0.2% | 1.84% | +2.9% |
| Q1 2016 | $35,013,000 | +3.8% | 369,107 | +1.6% | 1.78% | +3.4% |
| Q4 2015 | $33,741,000 | +9.1% | 363,272 | +0.1% | 1.72% | +4.4% |
| Q3 2015 | $30,914,000 | -1.7% | 362,793 | -1.3% | 1.65% | +1.7% |
| Q2 2015 | $31,446,000 | +2.0% | 367,408 | +1.2% | 1.62% | +0.2% |
| Q1 2015 | $30,820,000 | +1.3% | 363,013 | +2.3% | 1.62% | -3.3% |
| Q4 2014 | $30,424,000 | -61.1% | 354,968 | -65.1% | 1.68% | +11.9% |
| Q3 2014 | $78,247,000 | +198.8% | 1,017,809 | +206.0% | 1.50% | -0.5% |
| Q2 2014 | $26,183,000 | +15.1% | 332,573 | +9.7% | 1.51% | +9.1% |
| Q1 2014 | $22,745,000 | +1.4% | 303,268 | +4.4% | 1.38% | +0.7% |
| Q4 2013 | $22,431,000 | +12.1% | 290,551 | +0.6% | 1.37% | +1.6% |
| Q3 2013 | $20,013,000 | +10.2% | 288,708 | +0.7% | 1.35% | +4.2% |
| Q2 2013 | $18,153,000 | – | 286,779 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |